About 59 Trademarks found for “*MAB”

Computer hardware and software, namely electronic brake controllers and parts thereof; vehicle braking systems and parts thereof.

Pharmaceutical preparations for the treatment of oncological diseases and disorders.

Pharmaceutical preparations and compositions for treatment of cancer.

Analytical services for the research or screening of molecules or biological samples; pharmaceutical and biological research services, namely, antibody production, antibody characterization, and antibody purification.

Pharmaceutical preparations for human use, namely for use in oncology, for the treatment of cancer, for the treatment of cardiovascular diseases, antivirals, for the treatment of inflammatory bowel diseases, for the treatment of inflammatory connective tissue diseases, for the treatment of arthritis, for the treatment of urological diseases, for the treatment of psychiatric diseases, namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, for the treatment of neurological and neurodegenerative diseases and disorders, namely, Alzheimer's related dementia, Huntington's disease, Parkinson's disease, cerebral palsy, brain injury and diseases, spinal cord injury and diseases, seizure disorders, epilepsy, encephalitis, central nervous system movement disorders, ocular motility disorders, dystonias, blepharospasm, strabismus, facial scoliosis and tics, cerebral ischemia, dementia, amyotrophic sclerosis and multiple/lateral sclerosis, for the treatment of autoimmune diseases, for treating transplant rejections, for treatment of ophthalmic diseases, namely proliferative and non-proliferative diabetic retinopathy, macular degeneration, age-related macular degeneration, retinal neovascularisation, choroidal neovascularization, retinopathy, retinal vein occlusion, retinitis pigmentosa, uveitis, macular edema, macular edema cistoide, peptides.

Printed educational and informational publications related to cancer, namely, pamphlets, newsletters, guides.

Biopharmaceutical and biotechnology reagents, namely recombinant-generated antibodies and mammalian antibodies including human antibodies and recombinant fragments thereof for commercial purposes; diagnostic preparations for laboratory and/or medical research purposes; Biopharmaceutical and biotechnological reagents, namely recombinant-generated antibodies and mammalian antibodies including human antibodies and recombinant fragments thereof for scientific and medical research use; polypeptides for use in the biopharmaceutical industry; Biopharmaceutical preparations for the treatment of cancer; biopharmaceutical preparations for use in immunotherapy and diagnostics including monoclonal antibodies and binding fragments thereof and immunoconjugates, namely for the treatment of cancer; biopharmaceutical preparations for use in immunotherapy, including recombinant-generated antibodies and mammalian antibodies including human antibodies and recombinant fragments thereof; human vaccines; diagnostic preparations for medical laboratory use, medical diagnostic use and medical research use; monoclonal antibodies, human antibodies, immune toxins, toxin proteins and proteins for clinical or medical laboratory use; nucleic acids; cells for scientific use; libraries of fusion proteins and antibodies, libraries of cells producing antibodies, libraries of vector coding for antibodies and fusion proteins

Biotech products developed from rabbit cells for making monoclonal antibodies for research, diagnostic and therapeutic applications.